3 new articles: UPC News, SEP lobbying, pharma injunction lifted

1) UPC News (week of July 21, 2025)

This is the new structure of our Unified Patent Court Roundup, which is now developing throughout the week. Quick explainer: You get a UPC Roundup of the same structure as always when the week is over, but now you can see it developing during the course of the week.

For example, you can find a summary of the third contempt-of-court ruling in UPC history on that page now.

2) Increased ACT pro-SEP regulation activities in India are “scaremongering” but “worrisome”, say SEP holders

ACT | The App Association has substantially stepped up its level of activity in India, as well as parts of Latin America, with SEP holders calling its actions “misplaced alarmism” and playing into the Indian government’s SME innovation concerns.

3) U.S. appeals court revokes Novartis short-term injunction in Entresto patent dispute against MSN

The decision allows MSN to launch its generic version of Entresto into the market, and opens the door for others to follow.